Together, these data suggest that in the mouse model of AOM/DSS-induced colon cancer, Crhr2 deficiency exacerbates tumorigenicity, while loss of Crhr1 does not seem to alter the intestinal tumor development and growth. The gene discussed is CRHR1; the disease is intestinal neoplasm.